Search - tctmd.com

Displaying 1 - 20 of 27

Sort: Relevancy | Date

News Daily News

Side Effects of Statins Might Be Overstated: CTT Collaboration

Michael O'Riordan

February 12, 2026

News Daily News

Use of Secondary CVD Prevention Meds Still Meager Worldwide

Caitlin E. Cox

February 03, 2025

News Daily News

FDA Approves First ‘Near-Complete’ Stabilizer to Treat ATTR Cardiomyopathy

L.A. McKeown

November 25, 2024

News Conference News ESC 2023

More Details on Acoramidis’ Benefit in ATTR Cardiomyopathy: ATTRibute-CM

Michael O'Riordan

August 31, 2023

News Opinion CV Team Dispatch

February 2023 News Roundup

L.A. McKeown

February 15, 2023

News Industry News

TRANSFORM 1 Enrollment Completed: A Crucial RCT ready to redefine the DCB Angioplasty Mechanism

September 13, 2022

News Daily News

Age and Fitness Biggest Predictors of Mortality in CAD Patients, AI Study Shows

Michael O'Riordan

May 04, 2022

News Daily News

Absence of CAC May be Protective Even in Patients With Very High Cholesterol

Michael O'Riordan

February 14, 2022

News Daily News

Platelet Tests Pre-CABG May Safely Shorten Washout Waits, Cut Costs

Yael L. Maxwell

March 09, 2021

News Daily News

REPLACE COVID Bolsters Advice to Continue RAAS Inhibitors in COVID-19 Patients

Todd Neale

January 13, 2021

News Industry News

MagicTouch SCB Granted 'Breakthrough Device Designation' for the treatment of Small Coronary Artery Lesions.

December 16, 2020

News Conference News

‘Healing’ Stent Noninferior to Permanent-Polymer Device: PIONEER III

Shelley Wood

November 19, 2020

News Conference News CRT 2020

PCI-Related MIs Not Linked to Mortality at 1 Year: Onyx ONE

Michael O'Riordan

February 25, 2020

News Daily News

Baseline Ischemia Not Linked to 10-Year Events in Stable CAD: MASS II Analysis

Shelley Wood

July 23, 2019

News Conference News EAS 2019

CHD Mortality Significantly Elevated in Patients With Severe FH

Michael O'Riordan

May 29, 2019

News Conference News EuroPCR 2019

Daring to Dream: New BRS Data Hint at Low MACE Rates at 2 and 3 Years

Michael O'Riordan

May 27, 2019

News Conference News ACC 2019

New DECLARE-TIMI 58 Data Shine a Light on Diabetes Patients Most Likely to Benefit From Dapagliflozin

Shelley Wood

March 26, 2019

News Conference News ACC 2019

No TREAT for Ticagrelor at 12 Months: Fibrinolysis Patients After STEMI Do Just as Well on Clopidogrel

Shelley Wood

March 19, 2019

News Daily News

ESC Consensus Statement Tackles Inflammation, Cholesterol Connection in a Post-CANTOS World

Caitlin E. Cox

May 16, 2018

News Conference News ACC 2018

TREAT: No Major Bleeds With Ticagrelor in ACS Patients After Fibrinolysis

Shelley Wood

March 11, 2018

Advertisement

Side Effects of Statins Might Be Overstated: CTT Collaboration

Use of Secondary CVD Prevention Meds Still Meager Worldwide

FDA Approves First ‘Near-Complete’ Stabilizer to Treat ATTR Cardiomyopathy

More Details on Acoramidis’ Benefit in ATTR Cardiomyopathy: ATTRibute-CM

February 2023 News Roundup

TRANSFORM 1 Enrollment Completed: A Crucial RCT ready to redefine the DCB Angioplasty Mechanism

Age and Fitness Biggest Predictors of Mortality in CAD Patients, AI Study Shows

Absence of CAC May be Protective Even in Patients With Very High Cholesterol

Platelet Tests Pre-CABG May Safely Shorten Washout Waits, Cut Costs

REPLACE COVID Bolsters Advice to Continue RAAS Inhibitors in COVID-19 Patients

MagicTouch SCB Granted 'Breakthrough Device Designation' for the treatment of Small Coronary Artery Lesions.

‘Healing’ Stent Noninferior to Permanent-Polymer Device: PIONEER III

PCI-Related MIs Not Linked to Mortality at 1 Year: Onyx ONE

Baseline Ischemia Not Linked to 10-Year Events in Stable CAD: MASS II Analysis

CHD Mortality Significantly Elevated in Patients With Severe FH

Daring to Dream: New BRS Data Hint at Low MACE Rates at 2 and 3 Years

New DECLARE-TIMI 58 Data Shine a Light on Diabetes Patients Most Likely to Benefit From Dapagliflozin

No TREAT for Ticagrelor at 12 Months: Fibrinolysis Patients After STEMI Do Just as Well on Clopidogrel

ESC Consensus Statement Tackles Inflammation, Cholesterol Connection in a Post-CANTOS World

TREAT: No Major Bleeds With Ticagrelor in ACS Patients After Fibrinolysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content